ENZ - Enzo Biochem, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5174.06M
Enterprise Value 3114.73M
Trailing P/E 81.33
Forward P/E 1-9.38
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.01
Price/Book (mrq)1.91
Enterprise Value/Revenue 31.32
Enterprise Value/EBITDA 6-4.76

Trading Information

Stock Price History

Beta (3Y Monthly) 1.52
52-Week Change 3-22.73%
S&P500 52-Week Change 36.70%
52 Week High 35.0000
52 Week Low 32.3200
50-Day Moving Average 33.7291
200-Day Moving Average 33.4334

Share Statistics

Avg Vol (3 month) 3236.46k
Avg Vol (10 day) 3243.08k
Shares Outstanding 547.24M
Float 35.64M
% Held by Insiders 17.45%
% Held by Institutions 175.80%
Shares Short (Jun 28, 2019) 41.02M
Short Ratio (Jun 28, 2019) 43.31
Short % of Float (Jun 28, 2019) 42.27%
Short % of Shares Outstanding (Jun 28, 2019) 42.14%
Shares Short (prior month May 31, 2019) 41.31M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2100/105
Last Split Date 3Oct 21, 2004

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 31, 2018
Most Recent Quarter (mrq)Apr 30, 2019


Profit Margin 2.44%
Operating Margin (ttm)-31.42%

Management Effectiveness

Return on Assets (ttm)-15.73%
Return on Equity (ttm)2.38%

Income Statement

Revenue (ttm)86.7M
Revenue Per Share (ttm)1.84
Quarterly Revenue Growth (yoy)-22.10%
Gross Profit (ttm)44.33M
EBITDA -24.09M
Net Income Avi to Common (ttm)2.11M
Diluted EPS (ttm)0.0450
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)64.05M
Total Cash Per Share (mrq)1.35
Total Debt (mrq)4.73M
Total Debt/Equity (mrq)5.20
Current Ratio (mrq)5.61
Book Value Per Share (mrq)1.91

Cash Flow Statement

Operating Cash Flow (ttm)5.72M
Levered Free Cash Flow (ttm)-20.89M